Eyepoint Pharmaceuticals Inc
|
Q2 2019
Filed on Aug 14, 2019
|
226,802
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
144,194
|
$107.11 - $132.09
$15.4M - $19M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
234,000
|
$17.38 - $26.88
$4.07M - $6.29M
|
|
Proteostasis Therapeutics In
|
Q1 2019
Filed on May 15, 2019
|
419,000
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
71,500
|
$86.15 - $100.49
$6.16M - $7.19M
|
|
|
Q1 2019
Filed on May 15, 2019
|
180,000
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
1,343,181
|
$8.16 - $13.42
$11M - $18M
|
|
|
Q1 2019
Filed on May 15, 2019
|
109,117
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
622,548
|
$9.5 - $19.16
$5.91M - $11.9M
|
|
|
Q1 2019
Filed on May 15, 2019
|
108,400
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
333,902
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
767,000
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
296,099
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
129,000
|
N/A
|
|
|
Q1 2019
Filed on May 15, 2019
|
566,800
|
$52.36 - $69.88
$29.7M - $39.6M
|
|
|
Q1 2019
Filed on May 15, 2019
|
475,000
|
$4.12 - $10.25
$1.96M - $4.87M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
1,779,094
|
$5.22 - $10.44
$9.29M - $18.6M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
20,000,000
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
239,000
|
$29.75 - $42.9
$7.11M - $10.3M
|
|
Foamix Pharmaceuticals LTD
|
Q4 2018
Filed on Feb 14, 2019
|
234,745
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
420,409
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
708,873
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
275,000
|
$39.11 - $75.15
$10.8M - $20.7M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
225,000
|
$31.59 - $62.65
$7.11M - $14.1M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
120,000
|
$20.9 - $32.57
$2.51M - $3.91M
|
|
Nightstar Therapeutics PLC
|
Q4 2018
Filed on Feb 14, 2019
|
499,747
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
287,000
|
$16.51 - $51.33
$4.74M - $14.7M
|
|
Pernix Therapeutics Hldgs In
|
Q4 2018
Filed on Feb 14, 2019
|
658,826
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
241,430
|
$22.8 - $33.93
$5.5M - $8.19M
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
3,514,084
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
349,539
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,801,353
|
$4.75 - $14.5
$8.56M - $26.1M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
21,000,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
531,000
|
$60.76 - $73.81
$32.3M - $39.2M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
229,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
2,336,889
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
918,120
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
425,000
|
$13.02 - $17.54
$5.53M - $7.45M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
27,019,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
43,000,000
|
N/A
|
|
Aegerion Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
16,600,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,764,889
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
650,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
40,500,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
179,381
|
$36.35 - $51.7
$6.52M - $9.27M
|
|
Aralez Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
1,644,583
|
N/A
|
|
Arena Pharmaceuticals Inc
|
Q3 2018
Filed on Nov 14, 2018
|
398,194
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
628,262
|
$12.7 - $15.79
$7.98M - $9.92M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
810,000
|
$39.61 - $42.76
$32.1M - $34.6M
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
1,020,000
|
N/A
|
|